Skip to main content
Clinical Trials/NCT04548076
NCT04548076
Completed
N/A

Investigation of Analgesic Efficacy of Thoracolumbar Interfascial Plane Block in Vertebral Surgery

Tokat Gaziosmanpasa University1 site in 1 country64 target enrollmentSeptember 7, 2020
ConditionsBlock

Overview

Phase
N/A
Intervention
Not specified
Conditions
Block
Sponsor
Tokat Gaziosmanpasa University
Enrollment
64
Locations
1
Primary Endpoint
Visual analog scale
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

To determine the postoperative analgesic efficiency of thoracolumbar interfascial plane block , patients are divided into two groups. Study group received ultrasound-guided thoracolumbar interfascial plane block , where control had none. Visual analog scale and opioid consumption are recorded.

Detailed Description

Thoracolumbar interfascial plane block has successfully been demonstrated to provide an efficient analgesia in patients. The present study is aimed to investigate the intraoperative hemodynamic responses, anesthetic and analgesic consumption, and postoperative recovery quality of thoracolumbar interfascial plane block in patients with vertebral surgery. After approval, patients enrolled in the study are divided into two groups by computer-based randomization technique as control and study group. After standard monitorization, anesthesia induction and tracheal intubation, erector spinae plane block is performed to study group and no intervention to control group. In the intraoperative period, 10 mg / kg paracetamol and 0.05 mg / kg morphine will be used for postoperative analgesia. After surgery, all patients will be given 10 mg/kg paracetamol every 8 hours and will be fitted with a patient-controlled analgesia (PCA) device (Tramadol HCL). PCA device bolus dose will be set to 20 mg, lock time will be set to 10 minutes and the number of buttons per hour will be set as 3.for postoperative analgesia.After surgery, VAS scores of the patients will be evaluated (in the recovery room, 1,3,6,12 and 24 hours, Patients with VAS\>4 will be given 0.03mg / kg morphine as salvage analgesia.After 30 minutes, the patients' VAS will be re-evaluated,If VAS\>4 the same dose will be repeated. A patient satisfaction questionnaire (Qr40)will be filled by patients at the postoperative 24th hour.

Registry
clinicaltrials.gov
Start Date
September 7, 2020
End Date
November 7, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tokat Gaziosmanpasa University
Responsible Party
Principal Investigator
Principal Investigator

Hakan Tapar

Tokat Gaziosmanpasa University

Tokat Gaziosmanpasa University

Eligibility Criteria

Inclusion Criteria

  • Over 18 years of age, Planned to vertebral surgery, An American Society of Anesthesiologists score of 1,2 or 3

Exclusion Criteria

  • Severe cardiovascular disease, Psychiatric diseases, Rejected to participation, Those who have chronic pain

Outcomes

Primary Outcomes

Visual analog scale

Time Frame: one time in postoperative period for one year

Visual analog scale

Secondary Outcomes

  • Opioid consumption(During postoperative period for one yea)

Study Sites (1)

Loading locations...

Similar Trials